Hints and tips:
Related Special Reports
...to rescue Farfetch Regulators even out the antitrust score Global regulators had been on a losing streak lately, with back-to-back losses including Amgen’s $28bn takeover of fellow drugmaker Horizon Therapeutics...
...I always find that my clients who receive therapeutic support and who have a strong support network are more confident in their decision-making....
...Scientists at the Francis Crick Institute in London said their findings of a study conducted on mice, reported in the journal Nature, should not raise safety concerns but suggested a possible therapeutic...
...The plaques are suspected to be a driving factor in Alzheimer’s; removing them has long seemed a sensible therapeutic strategy....
...“We try and forage on the east and south coast for the berries when in season as much as we can, or we use Miles Irving at Forager Ltd, who is based in Kent,” says co-founder Imogen Davis....
...It has also narrowed its focus on two therapeutic areas: oncology and neurology....
...“The goal is actually to build an underlying platform which is . . . agnostic to those therapeutic areas,” he said....
...First, its $2.6bn purchase of Aimmune Therapeutics in 2020 — the company behind a medication aimed at combating the frequency and severity of allergic reactions to peanuts in children....
...Zhao declined to comment. 12) Telis Bioscience ($1mn for 2pc) CEO Grigory Khimulya says Telis Bioscience is “a venture-backed biotech company in Cambridge, MA engineering high-impact protein therapeutics...
...Decibel Therapeutics, Frequency Therapeutics and Sensorion, which recently announced a partnership with Sonova, are among those that have already gone public....
...“The EUSA Pharma acquisition represents an excellent opportunity to further expand and reinforce our portfolio in a new and under served therapeutic area (rare and niche oncology) with high potential growth...
...Beijing has never authorised mRNA products for therapeutic use, putting domestic drug companies on the back foot as the strength of the technology became evident during the pandemic....
...Substantial progress has been made in therapeutics and preventive approaches: pre-exposure prophylaxis, or PrEP, almost fully cuts the risk of catching the virus that can cause Aids....
...Meanwhile, US start-up Intellia Therapeutics has successfully treated the first patients using a Crispr gene-editing therapy directed inside the body to an internal organ — a breakthrough, with the technology...
...Since then it has been involved in 29 biotech companies, with successes including gene therapy specialists Orchard Therapeutics and Spark Therapeutics and cell therapy company TiGenix....
...Perhaps it was the therapeutic nature of endlessly circling something, or simply a coping mechanism to make up for the lack of competitive professional sport, but gliding around the streets of Monte Carlo...
...Ebb Therapeutics’ CoolDrift Luxe is a well thought out and constructed medical advice that aims to soothe our fevered brows and brains....
...Adam Barker, analyst at Shore Capital, said the deal was a sign of Astra’s commitment to innovative cancer therapeutics....
...Paul Fehlner, former patent chief at Swiss drugmaker Novartis and now current chief executive of Revision Therapeutics, said pharma companies are more likely to make their drugs cheaper if there is a clear...
...America’s square footage may save more relationships than anything else: but don’t discount that pink karaoke mike, the joy of cleaning closets, or the therapeutic effect of Qing-era soap opera....
...Suzanne Filippi, former corporate counsel consultant at Sage Therapeutics, has joined Hogan Lovells’ Boston office as a corporate partner in the life sciences and healthcare industry group....
...One mystery here is the identity of the investment consortia buyers, “Gemstone Investment Holding Ltd” and “Allied Cigar Corporation, S.L”....
...Its multiple sclerosis treatment Tecfidera now has a rival from Genentech, and a muscular dystrophy drug Spinraza is expected soon to have a new rival from PTC Therapeutics....
...Public market shareholders were burnt on Thursday as Biogen dropped dramatically and even companies with different approaches to Alzheimer’s fell: Alector was down 2 per cent and Denali Therapeutics dropped...
...Few analysts anticipate major regulatory risks to the deal because there is little overlap between the two companies’ therapeutic domains, product lines and geographic presence....
International Edition